178 related articles for article (PubMed ID: 32669514)
1. The Association between Frailty and Abdominal Symptoms: A Hospital-based Cross-sectional Study.
Asaoka D; Takeda T; Inami Y; Abe D; Shimada Y; Matsumoto K; Ueyama H; Matsumoto K; Komori H; Akazawa Y; Osada T; Hojo M; Nagahara A
Intern Med; 2020; 59(14):1677-1685. PubMed ID: 32669514
[TBL] [Abstract][Full Text] [Related]
2. Association between the severity of constipation and sarcopenia in elderly adults: A single-center university hospital-based, cross-sectional study.
Asaoka D; Takeda T; Inami Y; Abe D; Shimada Y; Matsumoto K; Ueyama H; Matsumoto K; Komori H; Akazawa Y; Osada T; Hojo M; Nagahara A
Biomed Rep; 2021 Jan; 14(1):2. PubMed ID: 33235719
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
Miyamoto M; Manabe N; Haruma K
Intern Med; 2010; 49(15):1469-76. PubMed ID: 20686276
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy.
Kawara F; Fujita T; Morita Y; Uda A; Masuda A; Saito M; Ooi M; Ishida T; Kondo Y; Yoshida S; Okuno T; Yano Y; Yoshida M; Kutsumi H; Hayakumo T; Yamashita K; Hirano T; Hirai M; Azuma T
World J Gastroenterol; 2017 Mar; 23(11):2060-2067. PubMed ID: 28373773
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users.
Asaoka D; Takeda T; Sasaki H; Shimada Y; Matsumoto K; Ueyama H; Matsumoto K; Izumi K; Komori H; Akazawa Y; Osada T; Hojo M; Nagahara A
Biomed Rep; 2019 May; 10(5):277-282. PubMed ID: 31086661
[TBL] [Abstract][Full Text] [Related]
6. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery.
Reisinger KW; van Vugt JL; Tegels JJ; Snijders C; Hulsewé KW; Hoofwijk AG; Stoot JH; Von Meyenfeldt MF; Beets GL; Derikx JP; Poeze M
Ann Surg; 2015 Feb; 261(2):345-52. PubMed ID: 24651133
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
8. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy.
Miyamoto M; Haruma K; Takeuchi K; Kuwabara M
J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive nutritional status in sarco-osteoporotic older fallers.
Huo YR; Suriyaarachchi P; Gomez F; Curcio CL; Boersma D; Gunawardene P; Demontiero O; Duque G
J Nutr Health Aging; 2015 Apr; 19(4):474-80. PubMed ID: 25809813
[TBL] [Abstract][Full Text] [Related]
10. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
Lacy BE; Chehade R; Crowell MD
Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
[TBL] [Abstract][Full Text] [Related]
11. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients.
Komatsu-Tanaka M; Iwakiri R; Fujimoto K; Fujiwara Y; Inamori M; Tanaka J; Shimatani T; Akiyama J; Ando T; Manabe N; Kinjo F; Deguchi R; Kusano M
Dig Endosc; 2012 Nov; 24(6):407-11. PubMed ID: 23078431
[TBL] [Abstract][Full Text] [Related]
12. Grip strength measurement for frailty assessment in patients with vascular disease and associations with comorbidity, cardiac risk, and sarcopenia.
Reeve TE; Ur R; Craven TE; Kaan JH; Goldman MP; Edwards MS; Hurie JB; Velazquez-Ramirez G; Corriere MA
J Vasc Surg; 2018 May; 67(5):1512-1520. PubMed ID: 29276105
[TBL] [Abstract][Full Text] [Related]
13. Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys.
Yoshimura N; Muraki S; Oka H; Iidaka T; Kodama R; Horii C; Kawaguchi H; Nakamura K; Akune T; Tanaka S
Osteoporos Int; 2018 Oct; 29(10):2181-2190. PubMed ID: 29931626
[TBL] [Abstract][Full Text] [Related]
14. Osteosarcopenia, the co-existence of osteoporosis and sarcopenia, is associated with social frailty in older adults.
Inoue T; Maeda K; Satake S; Matsui Y; Arai H
Aging Clin Exp Res; 2022 Mar; 34(3):535-543. PubMed ID: 34491548
[TBL] [Abstract][Full Text] [Related]
15. Japanese apricot improves symptoms of gastrointestinal dysmotility associated with gastroesophageal reflux disease.
Maekita T; Kato J; Enomoto S; Yoshida T; Utsunomiya H; Hayashi H; Hanamitsu T; Inoue I; Maeda Y; Moribata K; Muraki Y; Shingaki N; Deguchi H; Ueda K; Iguchi M; Tamai H; Ichinose M
World J Gastroenterol; 2015 Jul; 21(26):8170-7. PubMed ID: 26185391
[TBL] [Abstract][Full Text] [Related]
16. Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
Fujiwara Y; Habu Y; Ashida K; Kusano M; Higuchi K; Arakawa T
Digestion; 2013; 88(3):145-52. PubMed ID: 24008338
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Proton Pump Inhibitor for Sleep Bruxism: A Randomized Clinical Trial.
Ohmure H; Kanematsu-Hashimoto K; Nagayama K; Taguchi H; Ido A; Tominaga K; Arakawa T; Miyawaki S
J Dent Res; 2016 Dec; 95(13):1479-1486. PubMed ID: 27474257
[TBL] [Abstract][Full Text] [Related]
18. Frailty and sarcopenia do not predict adverse events in an elderly population undergoing non-complex primary elective surgery for degenerative conditions of the lumbar spine.
Charest-Morin R; Street J; Zhang H; Roughead T; Ailon T; Boyd M; Dvorak M; Kwon B; Paquette S; Dea N; Fisher CG; Flexman AM
Spine J; 2018 Feb; 18(2):245-254. PubMed ID: 28709946
[TBL] [Abstract][Full Text] [Related]
19. Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV.
Hawkins KL; Zhang L; Ng DK; Althoff KN; Palella FJ; Kingsley LA; Jacobson LP; Margolick JB; Lake JE; Brown TT; Erlandson KM
AIDS; 2018 Jun; 32(10):1257-1266. PubMed ID: 29794494
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
Takeuchi T; Hongo H; Kimura T; Kojima Y; Harada S; Ota K; Takeuchi N; Noguchi T; Inoue T; Murano M; Higuchi K
J Gastroenterol; 2019 Nov; 54(11):972-983. PubMed ID: 31037449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
